Harvard Management Company’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-281,189
| Closed | -$7.48M | – | 44 |
|
|
2023
Q1 | $7.48M | Sell |
281,189
-281,190
| -50% | -$7.48M | 0.79% | 19 |
|
|
2022
Q4 | $10.9M | Hold |
562,379
| – | – | 1.35% | 10 |
|
|
2022
Q3 | $11.7M | Hold |
562,379
| – | – | 1.46% | 11 |
|
|
2022
Q2 | $4.51M | Hold |
562,379
| – | – | 0.52% | 24 |
|
|
2022
Q1 | $3.94M | Hold |
562,379
| – | – | 0.4% | 31 |
|
|
2021
Q4 | $7.59M | Hold |
562,379
| – | – | 0.71% | 29 |
|
|
2021
Q3 | $9.49M | Hold |
562,379
| – | – | 0.56% | 24 |
|
|
2021
Q2 | $16.4M | Hold |
562,379
| – | – | 0.94% | 18 |
|
|
2021
Q1 | $22.1M | Hold |
562,379
| – | – | 1.24% | 15 |
|
|
2020
Q4 | $12.8M | Hold |
562,379
| – | – | 0.69% | 16 |
|
|
2020
Q3 | $12.7M | Hold |
562,379
| – | – | 0.7% | 14 |
|
|
2020
Q2 | $18.3M | Buy |
+562,379
| New | +$18.3M | 1.56% | 9 |
|